These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 27449755)
21. Suppression of epidermal growth factor receptor signaling by protein kinase C-alpha activation requires CD82, caveolin-1, and ganglioside. Wang XQ; Yan Q; Sun P; Liu JW; Go L; McDaniel SM; Paller AS Cancer Res; 2007 Oct; 67(20):9986-95. PubMed ID: 17942932 [TBL] [Abstract][Full Text] [Related]
22. T cells are crucial for the anti-metastatic effect of anti-epidermal growth factor receptor antibodies. Garrido G; Lorenzano P; Sánchez B; Beausoleil I; Alonso DF; Pérez R; Fernández LE Cancer Immunol Immunother; 2007 Nov; 56(11):1701-10. PubMed ID: 17415565 [TBL] [Abstract][Full Text] [Related]
23. Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: results of a Phase Ib/IIa study. Osorio M; Gracia E; Rodríguez E; Saurez G; Arango Mdel C; Noris E; Torriella A; Joan A; Gómez E; Anasagasti L; González JL; Melgares Mde L; Torres I; González J; Alonso D; Rengifo E; Carr A; Pérez R; Fernández LE Cancer Biol Ther; 2008 Apr; 7(4):488-95. PubMed ID: 18285705 [TBL] [Abstract][Full Text] [Related]
24. Racotumomab - a novel anti-idiotype monoclonal antibody vaccine for the treatment of cancer. Gajdosik Z Drugs Today (Barc); 2014 Apr; 50(4):301-7. PubMed ID: 24918647 [TBL] [Abstract][Full Text] [Related]
25. Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway. Yang J; Liao D; Chen C; Liu Y; Chuang TH; Xiang R; Markowitz D; Reisfeld RA; Luo Y Stem Cells; 2013 Feb; 31(2):248-58. PubMed ID: 23169551 [TBL] [Abstract][Full Text] [Related]
26. Racotumomab-alum vaccine for the treatment of non-small-cell lung cancer. Hernández AM; Vázquez AM Expert Rev Vaccines; 2015 Jan; 14(1):9-20. PubMed ID: 25420897 [TBL] [Abstract][Full Text] [Related]
27. Restoration of miR-7 expression suppresses the growth of Lewis lung cancer cells by modulating epidermal growth factor receptor signaling. Li J; Zheng Y; Sun G; Xiong S Oncol Rep; 2014 Dec; 32(6):2511-6. PubMed ID: 25334070 [TBL] [Abstract][Full Text] [Related]
28. Cancer vaccines: an update with special focus on ganglioside antigens. Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591 [TBL] [Abstract][Full Text] [Related]
29. Concomitant overexpression of EGFR and CXCR4 is associated with worse prognosis in a new molecular subtype of non-small cell lung cancer. Al Zobair AA; Al Obeidy BF; Yang L; Yang C; Hui Y; Yu H; Zheng F; Yang G; Xie C; Zhou F; Zhou Y Oncol Rep; 2013 Apr; 29(4):1524-32. PubMed ID: 23443279 [TBL] [Abstract][Full Text] [Related]
30. Pingyangmycin downregulates the expression of EGFR and enhances the effects of cetuximab on esophageal cancer cells and the xenograft in athymic mice. Gong JH; Liu XJ; Li Y; Zhen YS Cancer Chemother Pharmacol; 2012 May; 69(5):1323-32. PubMed ID: 22311160 [TBL] [Abstract][Full Text] [Related]
32. Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway. Li Y; Huang X; Zhang J; Li Y; Ma K Int J Biochem Cell Biol; 2013 Nov; 45(11):2349-58. PubMed ID: 23968914 [TBL] [Abstract][Full Text] [Related]
34. Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic Efficacy. Dai B; Yan S; Lara-Guerra H; Kawashima H; Sakai R; Jayachandran G; Majidi M; Mehran R; Wang J; Bekele BN; Baladandayuthapani V; Yoo SY; Wang Y; Ying J; Meng F; Ji L; Roth JA PLoS One; 2015; 10(6):e0123967. PubMed ID: 26053020 [TBL] [Abstract][Full Text] [Related]
35. Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation. Zhang F; Dong W; Zeng W; Zhang L; Zhang C; Qiu Y; Wang L; Yin X; Zhang C; Liang W Breast Cancer Res; 2016 Apr; 18(1):38. PubMed ID: 27036297 [TBL] [Abstract][Full Text] [Related]
36. Ganglioside GM3 exerts opposite effects on motility via epidermal growth factor receptor and hepatocyte growth factor receptor-mediated migration signaling. Li Y; Huang X; Wang C; Li Y; Luan M; Ma K Mol Med Rep; 2015 Apr; 11(4):2959-66. PubMed ID: 25503644 [TBL] [Abstract][Full Text] [Related]
37. Asialoglycoprotein receptor promotes cancer metastasis by activating the EGFR-ERK pathway. Ueno S; Mojic M; Ohashi Y; Higashi N; Hayakawa Y; Irimura T Cancer Res; 2011 Oct; 71(20):6419-27. PubMed ID: 21868757 [TBL] [Abstract][Full Text] [Related]
38. NEU3 activity enhances EGFR activation without affecting EGFR expression and acts on its sialylation levels. Mozzi A; Forcella M; Riva A; Difrancesco C; Molinari F; Martin V; Papini N; Bernasconi B; Nonnis S; Tedeschi G; Mazzucchelli L; Monti E; Fusi P; Frattini M Glycobiology; 2015 Aug; 25(8):855-68. PubMed ID: 25922362 [TBL] [Abstract][Full Text] [Related]
39. EGFR and microvessel density in canine malignant mammary tumours. Carvalho MI; Guimarães MJ; Pires I; Prada J; Silva-Carvalho R; Lopes C; Queiroga FL Res Vet Sci; 2013 Dec; 95(3):1094-9. PubMed ID: 24091029 [TBL] [Abstract][Full Text] [Related]
40. Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431. Meuillet EJ; Mania-Farnell B; George D; Inokuchi JI; Bremer EG Exp Cell Res; 2000 Apr; 256(1):74-82. PubMed ID: 10739654 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]